>
Switch to:

BridgeBio Pharma Price-to-Owner-Earnings

: (As of Today)
View and export this data going back to 2019. Start your Free Trial

As of today (2021-03-09), BridgeBio Pharma's share price is $59.480000. BridgeBio Pharma does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.



As of today (2021-03-09), BridgeBio Pharma's share price is $59.480000. BridgeBio Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-3.80. Therefore, BridgeBio Pharma's PE Ratio for today is .

As of today (2021-03-09), BridgeBio Pharma's share price is $59.480000. BridgeBio Pharma's EPS without NRI for the trailing twelve months (TTM) ended in was $-3.80. Therefore, BridgeBio Pharma's PE Ratio without NRI for today is .

BridgeBio Pharma Price-to-Owner-Earnings Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19 Dec20
Price-to-Owner-Earnings 0.00 0.00 0.00 0.00

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

BridgeBio Pharma Price-to-Owner-Earnings Distribution

* The bar in red indicates where BridgeBio Pharma's Price-to-Owner-Earnings falls into.


BridgeBio Pharma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

BridgeBio Pharma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=59.480000/0.00
=

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

BridgeBio Pharma  (NAS:BBIO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

BridgeBio Pharma Price-to-Owner-Earnings Related Terms

BridgeBio Pharma Price-to-Owner-Earnings Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)